|
||
| |||||||
|
|
Peakdale Molecular Launches New Website
Chapel-en-le-Frith, UK, 15th
May 2006 - Peakdale Molecular Ltd has announced the launch of its
newly designed website located at
www.peakdale.co.uk.
Over the past 6 months, the Company has substantially expanded its medicinal
chemistry capabilities and range of products and services for its
pharmaceutical and biotechnology customers.
The extended medicinal chemistry services has been specifically designed to complement customers' drug discovery initiatives through hit-to-lead and lead optimisation projects, patent protection projects, back-up chemotypes and fast follower candidate programmes. Peakdale’s full range of products, including peakexplorer™ GPCR libraries, peakfinder™ chemogenetic arrays for drug discovery, unique intermediates and screening compounds are also described in the new website. “Working with leading biotechs and 18 of the world’s top 20 pharma companies has enabled us to extend our service offering based on feedback from them.” commented Kim Morrison, CEO of Peakdale Molecular. These customers have an ever increasing need to accelerate their drug discovery initiatives and reduce failure rates during development. Our new products and services have been specifically designed to complement our existing range in order to meet this challenge.”
About Peakdale Molecular Ltd:
Peakdale Molecular was founded in 1992. Today, the
Company's customers include 18 of the top 20 global pharmaceutical companies
and an increasing number of biotechnology companies. Its teams of chemists
combine experience in pharmaceutical R&D and process development, medicinal
chemistry, parallel synthesis and fine chemicals to deliver unique chemistry
solutions to a range of drug discovery challenges.
Peakdale has earned a reputation from its
customers for the highest quality of service through its responsiveness,
dedication and rapid turnaround. The Company also has a reputation for
maintaining the highest standards of confidentiality and helping customers to
establish ownership of intellectual property.
Application of less commonly used chemistry, including high
temperature/pressure reactions, proprietary heterocyclic chemistry and
nucleoside synthesis, enables Peakdale's chemists to generate unique compounds
for drug discovery. Peakdale operates in several distinct markets providing
novel screening compounds, targeted screening libraries, catalogue
intermediates, custom synthesis and contract research. Further information
about the Company can be obtained at
www.peakdale.co.uk.
|
|
| ||||||||
